Technology | June 16, 2015

IBA Presents Fifth Academy on the Road Training Workshop

Two-day training offers continuing education in advanced accelerator beam data commissioning and annual checks

IBA, Academy on the Road, radiation therapy, training workshop

Shown here are some of the attending physicists participating in the set up of the Blue Phantom2 and LDA-99 Diode Array for an electron scan, which is required TG-106 protocol for annual and beam commissioning reports. Based upon feedback from attendees in all 5 sessions, the hands-on portion of our academy workshops is where it all comes together for practical use, says Tina Baker. This unique experience adds great value, and we are very happy to offer value-added programs.

June 16, 2015 - IBA (Ion Beam Applications S.A.) announced the successful completion of its fifth IBA Academy on the Road enhanced training workshop. This, and several other training offerings, are key cornerstones of the IBA CAREprogram initiative, which allows close partnering with IBA customers for optimized user satisfaction.

"The IBA sponsored workshop on Advanced Accelerator Beam Commissioning is a "˜must do' for all physicists responsible for beam commissioning. It is informative and entertaining, allowing for peer-to-peer networking and idea-swapping on a level that cannot be obtained elsewhere", said Peter Goyer, MS, DABR, medical physicist of Community Cancer Treatment Center at Geisinger-Lewistown Hospital. "The main speaker is a member of TG-106 and has decades of experience in beam commissioning. The relaxed atmosphere lends itself to learning and makes the hands-on portion truly useful. This workshop is easy to recommend."

The Commission on Accreditation of Medical Physics Education Programs (CAMPEP) approved the training to offer 14.25 MPCEC (Medical Physics Continuing Education Credit) upon completion.

For more information: www.iba-worldwide.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...